166 related articles for article (PubMed ID: 16048976)
1. Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice.
Pultz NJ; Donskey CJ
Antimicrob Agents Chemother; 2005 Aug; 49(8):3529-32. PubMed ID: 16048976
[TBL] [Abstract][Full Text] [Related]
2. Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice.
Adams DA; Riggs MM; Donskey CJ
Antimicrob Agents Chemother; 2007 Aug; 51(8):2674-8. PubMed ID: 17562807
[TBL] [Abstract][Full Text] [Related]
3. Orally administered beta-lactamase enzymes represent a novel strategy to prevent colonization by Clostridium difficile.
Stiefel U; Nerandzic MM; Koski P; Donskey CJ
J Antimicrob Chemother; 2008 Nov; 62(5):1105-8. PubMed ID: 18693236
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile and the disease it causes.
Norén T
Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
6. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.
Geric B; Carman RJ; Rupnik M; Genheimer CW; Sambol SP; Lyerly DM; Gerding DN; Johnson S
J Infect Dis; 2006 Apr; 193(8):1143-50. PubMed ID: 16544255
[TBL] [Abstract][Full Text] [Related]
7. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile--Second International Symposium (ICDS).
Tillotson G
IDrugs; 2007 Aug; 10(8):538-42. PubMed ID: 17665327
[No Abstract] [Full Text] [Related]
9. Colitis associated with Clostridium difficile in specific-pathogen-free C3H-scid mice.
Kawano A; Ikeda M; Iritani R; Kinoshita A; Watanabe K; Hayao T; Kokubo T; Matsushita S
J Vet Med Sci; 2007 Sep; 69(9):973-5. PubMed ID: 17917386
[TBL] [Abstract][Full Text] [Related]
10. Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile.
Limaye AP; Turgeon DK; Cookson BT; Fritsche TR
J Clin Microbiol; 2000 Apr; 38(4):1696-7. PubMed ID: 10747174
[TBL] [Abstract][Full Text] [Related]
11. Tigecycline exhibits inhibitory activity against Clostridium difficile in the colon of mice and does not promote growth or toxin production.
Jump RL; Li Y; Pultz MJ; Kypriotakis G; Donskey CJ
Antimicrob Agents Chemother; 2011 Feb; 55(2):546-9. PubMed ID: 21135181
[TBL] [Abstract][Full Text] [Related]
12. Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer.
Weiss K
Int J Antimicrob Agents; 2009 Jan; 33(1):4-7. PubMed ID: 18804351
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility of Clostridium difficile isolates from adult patients at two Jamaican hospitals. Clinical and epidemiological implications.
Heslop OD; King SD; Levett PN; Barton EN; Wynter J
West Indian Med J; 2001 Mar; 50(1):50-4. PubMed ID: 11398289
[TBL] [Abstract][Full Text] [Related]
14. Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice.
Kaur S; Vaishnavi C; Prasad KK; Ray P; Kochhar R
Microbiol Immunol; 2007; 51(12):1209-14. PubMed ID: 18094539
[TBL] [Abstract][Full Text] [Related]
15. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates.
Akerlund T; Svenungsson B; Lagergren A; Burman LG
J Clin Microbiol; 2006 Feb; 44(2):353-8. PubMed ID: 16455883
[TBL] [Abstract][Full Text] [Related]
16. Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.
Terhes G; Urbán E; Sóki J; Szikra L; Konkoly-Thege M; Vollain M; Nagy E
Anaerobe; 2009 Dec; 15(6):237-40. PubMed ID: 19682411
[TBL] [Abstract][Full Text] [Related]
17. Toxin production by and adhesive properties of Clostridium difficile isolated from humans and horses with antibiotic-associated diarrhea.
Taha S; Johansson O; Rivera Jonsson S; Heimer D; Krovacek K
Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):163-74. PubMed ID: 17239950
[TBL] [Abstract][Full Text] [Related]
18. Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.
Freeman J; Baines SD; Saxton K; Wilcox MH
J Antimicrob Chemother; 2007 Jul; 60(1):83-91. PubMed ID: 17483547
[TBL] [Abstract][Full Text] [Related]
19. Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile Infection.
Pollock NR
J Clin Microbiol; 2016 Feb; 54(2):259-64. PubMed ID: 26659205
[TBL] [Abstract][Full Text] [Related]
20. Multiple peracute deaths in a colony of Syrian hamsters (Mesocricetus auratus).
Hart M; O'Connor E; Davis M
Lab Anim (NY); 2010 Apr; 39(4):99-102. PubMed ID: 20305630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
